loading
Schlusskurs vom Vortag:
$3.01
Offen:
$3.04
24-Stunden-Volumen:
16,660
Relative Volume:
0.01
Marktkapitalisierung:
$6.87M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-1.5187
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
+18.18%
1M Leistung:
+19.49%
6M Leistung:
+7.26%
1J Leistung:
+6.91%
1-Tages-Spanne:
Value
$2.9804
$3.25
1-Wochen-Bereich:
Value
$2.65
$3.25
52-Wochen-Spanne:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Firmenname
Cyclerion Therapeutics Inc
Name
Telefon
617-621-7722
Name
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Name
Mitarbeiter
1
Name
Twitter
@Cyclerion
Name
Nächster Verdiensttermin
2024-12-15
Name
Neueste SEC-Einreichungen
Name
CYCN's Discussions on Twitter

Vergleichen Sie CYCN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
3.25 6.87M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-10-20 Eingeleitet Truist Buy
2021-09-24 Eingeleitet Cantor Fitzgerald Overweight
2019-06-03 Eingeleitet Credit Suisse Neutral

Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten

pulisher
Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025
pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025
pulisher
Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Cyclerion’s Stock Surge: A Buying Opportunity? - timothysykes.com

Feb 03, 2025
pulisher
Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025
pulisher
Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 31, 2025
pulisher
Jan 08, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 3.5% – Time to Buy? - Defense World

Jan 08, 2025
pulisher
Jan 03, 2025

Looking Into Cyclerion Therapeutics's Recent Short Interest - Benzinga

Jan 03, 2025
pulisher
Dec 23, 2024

Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress - Stocks Telegraph

Dec 23, 2024
pulisher
Dec 19, 2024

Cyclerion Therapeutics (NASDAQ: CYCN) Amends License Agreement with Akebia Therapeutics and Generates Revenues for GrowthOn December 17, 2024, Cyclerion Therapeutics, Inc. filed an 8-K SEC Filing which detailed significant developments in its b - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion Therapeutics Secures Funding and Expands CNS Focus - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Cyclerion advances growth strategy with new agreements By Investing.com - Investing.com UK

Dec 17, 2024

Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):